Oral use oftranexamic acid applied to cutaneous hyperpigmentation: a review
DOI:
https://doi.org/10.33448/rsd-v12i5.41769Keywords:
Tranexamic acid; Hyperpigmentation; Melanosis.Abstract
Hyperpigmentation of the skin, commonly called melasma, is a condition without a clear cause located on the face and characterized by irregular patches with a high degree of vascularity, intense brown coloration resulting from the deposition of melanin derived from the oxidation of tyrosine in melanocytes located in the basal layer of the epidermis. Although affecting both sexes, it occurs more frequently in women. Analyses indicate that a tranexamic acid is an option for melasma care, even though the available treatments do not have absolute efficacy. The objective of this article is to report on the action of tranexamic acid and its oral administration routes, with or without other treatment methods. The methodology used was an integrative review of double-blind studies, selecting 86 articles between 2012 and 2022, and applying inclusion and exclusion criteria. The results indicate that oral tranexamic acid is effective and has low side effects, which favors patient adherence to treatment, concluding that this therapy can be a promising option for melasma treatment.
References
Aamir, S., & Naseem, R. (2014). Oral tranexamic acid in treatment of melasma in Pakistani population: a pilot study. Journal of Pakistan Association of Dermatologists, 24(3), 198–203. https://www.jpad.com.pk/index.php/jpad/article/view/202
Appannavar, S., Rohith, & Pise, G. (2021). Efficacy of oral tranexamic acid versus triple combination for the treatment of melasma: A prospective, double blinded randomised controlled trial. IP Indian Journal of Clinical and Experimental Dermatology, 7(3), 222–227. https://doi.org/10.18231/j.ijced.2021.042
Ariembi, D., Widayati, R. I., & Malik, D. A. (n.d.). Eficácia do creme com ácido tranexâmico a 4% e laser QS Nd: YAG 1064 nm de baixa fluência no melasma: um estudo duplo-cego, randomizado e controlado. Surgical & Cosmetic Dermatology, 12(3), 215–221. https://www.redalyc.org/journal/2655/265565422003/html/
Cassiano, D., Esposito, A. C. C., Hassun, K., Bagatin, E., Lima, M. M. D. A., Lima, E. V. A., Miot, L. D. B., & Miot, H. A. (2020). Efficacy and safety of microneedling and oral tranexamic acid in the treatment of facial melasma in women: An open, evaluator-blinded, randomized clinical trial. Journal of the American Academy of Dermatology, 83(4), 1176–1178. https://doi.org/10.1016/j.jaad.2020.02.002
Cho, H. H., Choi, M., Cho, S., & Lee, J. H. (2011). Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser. Journal of Dermatological Treatment, 24(4), 292–296. https://doi.org/10.3109/09546634.2011.643220
Del Rosario, E., Florez-Pollack, S., Zapata, L., Hernandez, K., Tovar-Garza, A., Rodrigues, M., Hynan, L. S., & Pandya, A.
G. (2018). Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to- severe melasma. Journal of the American Academy of Dermatology, 78(2), 363–369. https://doi.org/10.1016/j.jaad.2017.09.053
Ebrahim, H. M., Said Abdelshafy, A., Khattab, F., & Gharib, K. (2020). Tranexamic Acid for Melasma Treatment: A Split- Face Study. Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery [et Al.], 46(11), e102–e107. https://doi.org/10.1097/DSS.0000000000002449
Kannambal.K, Thillaikkarasi. A., Prasad P.V.S, Kaviarasan.P.K,. (n.d.). Comparative Clinical Study of Oral Tranexamic Acid and Topical Tranexamic Acid with Microneedling in the Management of Melasma. Jmscr.igmpublication.org. https://jmscr.igmpublication.org/home/index.php/archive/144-volume-05-issue-11-november- 2017/3779-comparative-clinical-study-of-oral-tranexamic-acid-and-topical-tranexamic-acid-with-microneedling-in-the- management-of-melasma
Karn, D. K. C. S., Amatya, A., Razouria, E., & Timalsina, M. (2014). Oral Tranexamic Acid for the Treatment of Melasma. Kathmandu University Medical Journal, 10(4), 40–43. https://doi.org/10.3126/kumj.v10i4.10993
Lee, H. C., Thng, T. G. S., & Goh, C. L. (2016). Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis. Journal of the American Academy of Dermatology, 75(2), 385–392. https://doi.org/10.1016/j.jaad.2016.03.001
Mendes, K. D. S., Silveira, R. C. de C. P., & Galvão, C. M. (2019). Uso de gerenciador de referências bibliográficas na seleção dos estudos primários em revisão integrativa. Texto & Contexto -Enfermagem, 28. https://doi.org/10.1590/1980-265X-TCE-2017-0204
Misri, R., Khurana, V., Agarwal, S., Thole, A., Kumar, S., & Anand, T. (2019). A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma. Indian Journal of Dermatology, Venereology and Leprology, 85(1), 39. https://doi.org/10.4103/ijdvl.ijdvl_801_16
Na, J. I., Choi, S. Y., Yang, S. H., Choi, H. R., Kang, H. Y., & Park, K.-C. (2012). Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. Journal of the European Academy of Dermatology and Venereology, 27(8), 1035– 1039. https://doi.org/10.1111/j.1468-3083.2012.04464.x
Nguyen, J., Rajgopal Bala, H., Ross, A., Wong, C. C., Paul, E., & Rodrigues, M. (2020). Effect of oral tranexamic acid on erythema index in patients with melasma. Australasian Journal of Dermatology. https://doi.org/10.1111/ajd.13482
Sahu, P. J., Singh, A. L., Kulkarni, S., Madke, B., Saoji, V., & Jawade, S. (2020). Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman’s regimen in treatment of melasma. Journal of Cosmetic Dermatology, 19(6), 1456– 1462. https://doi.org/10.1111/jocd.13430
Tamega, A. de.A., Miot, L. D. B., Bonfietti, C., Gige, T. C., Marques, M. E. A., & Miot, H. A. (2012). Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women. Journal of the European Academy of Dermatology and Venereology, 27(2), 151–156. https://doi.org/10.1111/j.1468-3083.2011.04430.x
Tan, A. W. M., Sen, P., Chua, S. H., & Goh, B. K. (2016). Oral tranexamic acid lightens refractory melasma. Australasian Journal of Dermatology, 58(3), e105–e108. https://doi.org/10.1111/ajd.12474
V. Lajevardi, Afsaneh Ghayoumi, R. Abedini, Hosseini, H., Goodarzi, A., Akbari, Z., & Hedayat, K. (2017). Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel‐group, assessor‐ and analyst‐blinded, randomized controlled trial with a
short‐term follow‐up. Journal of Cosmetic Dermatology. https://www.semanticscholar.org/paper/Comparison-of-the- therapeutic-efficacy-and-safety-4-Lajevardi-Ghayoumi/
Vachiramon, V., Jurairattanaporn, N., Harnchoowong, S., & Chayavichitsilp, P. (2018). Non-invasive high-intensity focused ultrasound for UV-induced hyperpigmentation in Fitzpatrick skin types III and IV: a prospective, randomized, controlled, evaluator-blinded trial. Lasers in Medical Science, 33(2), 361–367. https://doi.org/10.1007/s10103-017-2393-5
Wang, W.-J., Wu, T.-Y., Tu, Y.-K., Kuo, K.-L., Tsai, C.-Y., & Chie, W.-C. (2023). The optimal dose of oral tranexamic acid in melasma: A network meta-analysis. Indian Journal of Dermatology, Venereology and Leprology, 89(2), 189–194. https://doi.org/10.25259/IJDVL_530_2021
Wu, S., Shi, H., Wu, H., Yan, S., Guo, J., Sun, Y., & Pan, L. (2012). Treatment of melasma with oral administration of tranexamic acid. Aesthetic Plastic Surgery, 36(4), 964–970. https://doi.org/10.1007/s00266-012-9899-9
Zhu, C.-Y., Li, Y., Sun, Q.-N., Takada, A., & Kawada, A. (2019). Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study. European Journal of Dermatology: EJD, 29(1), 55–58. https://doi.org/10.1684/ejd.2018.3494
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Cristiane Maria Barbosa da Silva; Natália Crisostimo Alves; Tibério Cesar Lima de Vasconcelos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
